World Plasma Fractionation Market - Opportunities and Forecasts, 2017-2023

Diagnostics and Biotech	LI 16943	Pages: NA	Formats*:
Sep 2017 \| 172 Views	Charts: NA	Tables: NA

Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation.

Increasing use of immunoglobulin in therapeutic areas and prevalence of emphysema & AATD are factors fueling the growth of the world plasma fractionation market. However, high cost, limited reimbursement, and stringent government regulations obstruct growth of the market. On the other hand, increasing number of hemophilic patients are creating opportunities for growth.

The world plasma fractionation market is segmented based on product, application, end user, and geography. On the basis of products, the market is classified into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further classified into subcutaneous immunoglobulin (SCIg), intravenous immunoglobulin (IVIg), and others. Coagulation factor concentrates are divided into factor VIII, factor IX, factor XIII, Von Willebrand factor, prothrombin coagulation concentrates, and fibrinogen concentrates. Applications included in the report are neurology, hematology, immunology, critical care, and others. End users covered in the report are hospitals and clinical research laboratories. Geographically, the market is divided into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).

The prominent companies operating in the market are Grifols SA, Baxter International Inc., CSL Ltd., Bio Product Laboratory, Octapharma AG, Sanquin, Laboratoire Franais du Fractionnement et des Biotechnologies, Kedrion, and Biotest. Partnerships, collaborations, mergers & acquisitions, agreements, expansions, joint ventures, and others are some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market.

KEY BENEFITS FOR STAKEHOLDERS:

The report offers an in-depth analysis of key driving and restraining factors of the world plasma fractionation market.
This report offers an in-depth quantitative analysis of the current market and estimations through 2015-2020, which assists in identifying the prevailing market opportunities.
The report provides an extensive analysis of current and future market status of the world plasma fractionation market.
An in-depth analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
An in-depth analysis of current research and clinical developments within the world plasma fractionation market is provided with key market dynamic factors that helps in understanding the behaviour of the market.
Competitive intelligence (of leading manufacturers and distributors of plasma fractionation) helps in understanding the competitive scenario across geographies.
Geographically, the world plasma fractionation market is segmented into North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA).

KEY MARKET SEGMENTS:

The Plasma Fractionation Market By Product
- Albumin
- Immunoglobulins
  - Subcutaneous Immunoglobulin (SCIg)
  - Intravenous Immunoglobulin (IVIg)
  - Others
- Coagulation Factor Concentrates
  - Factor VIII
  - Factor IX
  - Factor XIII
  - Von Willebrand Factor
  - Prothrombin Coagulation Concentrates
  - Fibrinogen Concentrates
- Others
The Plasma Fractionation Market By Application
- Neurology
- Hematology
- Immunology
- Critical Care
- Others
The Plasma Fractionation Market By End User
- Hospitals
- Clinical Research Laboratories
The Plasma Fractionation Market By Geography
- North America
- Asia-Pacific
- Europe
- Latin America, Middle East and Africa (LAMEA)

Key Market Players:

Grifols SA
Baxter International Inc.
CSL Ltd.
Bio Product Laboratory
Octapharma AG
Sanquin
Laboratoire Franais du Fractionnement et des Biotechnologies
Kedrion
Biotest

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

License Type

Data Pack

Single User PDF

Five User Online/PDF

Enterprise Online/PDF

LICENSE INFO

Users/Sharing

Restricted to one authorized user

Limited to 5 authorized users

Unlimited within company / enterprise

Printing

One Print only